C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 746 shares of the biotechnology company’s stock, valued at approximately $298,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Mather Group LLC. boosted its stake in shares of Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after purchasing an additional 27 shares during the period. Dorsey Wright & Associates lifted its holdings in Axon Enterprise by 0.3% during the 2nd quarter. Dorsey Wright & Associates now owns 14,053 shares of the biotechnology company’s stock valued at $4,135,000 after buying an additional 39 shares in the last quarter. Avantax Advisory Services Inc. lifted its holdings in Axon Enterprise by 0.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after buying an additional 40 shares in the last quarter. Brookstone Capital Management increased its holdings in shares of Axon Enterprise by 5.1% in the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after acquiring an additional 41 shares during the period. Finally, CWM LLC lifted its position in Axon Enterprise by 1.5% during the second quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock valued at $830,000 after acquiring an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AXON. Bank of America began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective on the stock. Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. Craig Hallum upped their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC restated a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a report on Wednesday, August 7th. Finally, Barclays upped their price target on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $365.38.

Check Out Our Latest Stock Report on Axon Enterprise

Axon Enterprise Price Performance

AXON stock opened at $428.76 on Friday. The company has a 50 day simple moving average of $375.57 and a 200 day simple moving average of $326.60. The stock has a market cap of $32.40 billion, a price-to-earnings ratio of 113.13, a P/E/G ratio of 11.58 and a beta of 0.94. Axon Enterprise, Inc. has a 1 year low of $199.29 and a 1 year high of $433.48. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the previous year, the company posted $0.80 earnings per share. The company’s quarterly revenue was up 34.5% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 4,767 shares of the business’s stock in a transaction dated Thursday, October 3rd. The shares were sold at an average price of $404.14, for a total value of $1,926,535.38. Following the transaction, the chief executive officer now owns 2,925,060 shares in the company, valued at approximately $1,182,133,748.40. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the sale, the president now directly owns 228,166 shares in the company, valued at $82,103,253.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 4,767 shares of Axon Enterprise stock in a transaction that occurred on Thursday, October 3rd. The shares were sold at an average price of $404.14, for a total value of $1,926,535.38. Following the sale, the chief executive officer now owns 2,925,060 shares in the company, valued at $1,182,133,748.40. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 370,172 shares of company stock worth $136,562,182 in the last quarter. 6.10% of the stock is owned by insiders.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.